Cybersecurity Scan — August 28, 2026 Close
Cybersecurity Scan — August 28, 2026 Close
The whole board reversed higher this scan after last week's uniform cooling — OKTA led with a +22.91% week on an earnings beat plus four separate analyst price-target raises, and CRWD fully erased its prior -11.51% weekly drop with a +13.8% bounce. BB climbed back out of oversold, and every other name in the group posted a positive week. ZS remains the one structural exception: still only 4.8% above its 200-day with a -34.3% trailing year, even as it participates in the board-wide bounce.
Data as-of 2026-08-28 close. All numbers from precomputed summaries/cybersec.json. Prior scan: 2026-08-22-cybersec (2026-08-22, data as-of 2026-08-21 close) — the summary's own 7-day window runs 2026-08-21 to 2026-08-28, so the comparisons below line up exactly with that prior scan.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟢 A board-wide reversal higher after last scan's uniform cooling, led by OKTA's earnings beat and a wave of analyst price-target raises. |
| Key insight | OKTA's +22.91% week is backed by a real catalyst — a Q2 earnings beat (reported Aug 26) followed by same-day-adjacent price-target raises from Truist, Scotiabank, RBC, and Needham (all Aug 27) — not just a technical bounce. |
What's Going On
OKTA is the standout this scan. RSI climbed from 42.8 to 64.7, price from $135.14 to $166.23, and the week alone added 22.91% — the board's largest move by a wide margin. The news receipt on file (fetched Aug 27, fresh) shows a Q2 2027 earnings report on Aug 26 followed the next day by four separate analyst price-target increases: Truist to $200, Scotiabank to $190, RBC to $195, and Needham to $200. OKTA now sits 66.7% above its 200-day average with a trailing one-year return of +79.53% (alpha1y +59.66) — a real catalyst driving an already-strong trend further.
CRWD had the second-largest move, fully reversing last scan's sharpest weekly drop: RSI climbed from 42.8 to 58.2, price from $191.95 to $218.40, and the week added 13.8% after last scan's -11.51% slide. CRWD sits 55.5% above its 200-day with a trailing year of +97.65% — this reads as the deep pullback flagged last scan resolving back into the uptrend, not a new development.
The rest of the board moved in the same direction. FTNT reversed from -4.04% to +8.12% on the week (RSI 45.8→57.2), PANW from -6.89% to +3.88% (RSI 51.6→55.8), NET from -7.17% to +2.28% (RSI 52.2→54.3), and HACK, BUG, and CIBR all posted mid-single-digit weekly gains after last scan's board-wide easing. BB climbed back out of oversold entirely (RSI 36.4→44.1, week -9.56%→+1.49%, 30-day change -10.17%→+4.48%) while remaining up 113.05% over the trailing year. ZS is the one name whose longer-horizon picture didn't improve alongside the bounce: it's still only 4.8% above its 200-day with a trailing year of -34.3% (alpha1y -54.17) — participating in this week's gain (+1.29%) but not resolving the structural test flagged last scan.
What Changed Since Prior Scan (2026-08-21 close → 2026-08-28 close)
- OKTA led the board on an earnings beat and analyst upgrades: RSI 42.8→64.7, price $135.14→$166.23, 7D -8.28%→+22.91%, 30D -1.13%→+21.42%.
- CRWD fully reversed last scan's crash: RSI 42.8→58.2, price $191.95→$218.40, 7D -11.51%→+13.8%, 30D +1.87%→+21.75%.
- FTNT reversed higher: RSI 45.8→57.2, price $153.51→$166.00, 7D -4.04%→+8.12%, 30D -0.99%→+8.34%.
- PANW reversed higher: RSI 51.6→55.8, price $357.87→$371.59, 7D -6.89%→+3.88%, 30D +6.74%→+18.28%.
- NET reversed higher: RSI 52.2→54.3, price $293.14→$299.84, 7D -7.17%→+2.28%, 30D +8.98%→+10.9%.
- BB recovered out of oversold: RSI 36.4→44.1, price $8.04→$8.16, 7D -9.56%→+1.49%, 30D -10.17%→+4.48%.
- S held roughly flat: RSI 54.1→54.3, price $21.19→$21.54, 7D -8.31%→+1.84%, 30D +16.3%→+16.31%.
- ZS cooled slightly while the rest of the board rose: RSI 63.3→60.4, price $181.75→$184.23, 7D -0.96%→+1.29%, 30D +27.76%→+19.81%.
- HACK, BUG, CIBR all reversed higher in step with the board: HACK RSI 49.7→55.5, BUG 50.8→58.1, CIBR 50.1→57.0.
How To Read The Board
Every name except ZS carries a golden cross, and this scan is the mirror image of last one — every name posted a positive week after last scan's uniform easing. OKTA's move is the one backed by a confirmed catalyst (earnings beat plus multiple analyst target raises); the rest of the board's bounce reads as a broad recovery inside already-intact trends, with ten of eleven names sitting comfortably above their 200-day and carrying positive trailing-year returns. ZS remains the outlier — negative on the year, far off its high, and only marginally above its 200-day — the one name here where the long trend is still genuinely being tested even as it joins this week's gain.
Price Table
| Stock | Price | RSI | SMA20 | vs SMA | 7D% | 30D% | Signal |
|---|---|---|---|---|---|---|---|
| OKTA | $166.23 | 64.7 | $145.59 | +14.2% | +22.91% | +21.42% | 🟡 Neutral |
| ZS | $184.23 | 60.4 | $175.64 | +4.9% | +1.29% | +19.81% | 🟡 Neutral |
| CRWD | $218.40 | 58.2 | $208.95 | +4.5% | +13.8% | +21.75% | 🟡 Neutral |
| BUG | $42.95 | 58.1 | $41.62 | +3.2% | +5.51% | +15.83% | 🟡 Neutral |
| FTNT | $166.00 | 57.2 | $160.04 | +3.7% | +8.12% | +8.34% | 🟡 Neutral |
| CIBR | $98.56 | 57.0 | $97.21 | +1.4% | +3.89% | +11.00% | 🟡 Neutral |
| PANW | $371.59 | 55.8 | $366.86 | +1.3% | +3.88% | +18.28% | 🟡 Neutral |
| HACK | $115.54 | 55.5 | $114.49 | +0.9% | +3.59% | +11.22% | 🟡 Neutral |
| NET | $299.84 | 54.3 | $298.03 | +0.6% | +2.28% | +10.90% | 🟡 Neutral |
| S | $21.54 | 54.3 | $21.59 | -0.2% | +1.84% | +16.31% | 🟡 Neutral |
| BB | $8.16 | 44.1 | $8.51 | -4.1% | +1.49% | +4.48% | 🟡 Neutral |
Tier Analysis
Capitulation (RSI<25): None.
Oversold (25-40): None — BB (44.1) climbed back above the line this scan.
Neutral/Strong (40+): The entire board, spanning BB (44.1) to OKTA (64.7, the board's highest print).
Entry Zones
| Stock | Price | RSI | 30D% | Setup |
|---|---|---|---|---|
| OKTA | $166.23 | 64.7 | +21.42% | Biggest mover on the board — earnings beat plus four analyst price-target raises (all Aug 26-27) drove the week; now 66.7% above its 200-day |
| CRWD | $218.40 | 58.2 | +21.75% | Fully reversed last scan's steepest weekly drop; still 55.5% above its 200-day and up 97.65% over the trailing year |
| ZS | $184.23 | 60.4 | +19.81% | Still the one structurally weaker name — only 4.8% above its 200-day with a -34.3% trailing year, despite joining this week's gain |
| BB | $8.16 | 44.1 | +4.48% | Recovered out of oversold this week; still up 113.05% over the trailing year |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| 🔍 WATCH | OKTA | Biggest mover on a confirmed earnings beat and multiple analyst upgrades; confirm the extension holds |
| 🔒 HOLD | CRWD, FTNT, PANW, NET, S, HACK, BUG, CIBR | Reversed higher this week inside intact, well-above-200-day uptrends |
| 🔍 WATCH | ZS | Joined this week's bounce but is still the one name whose 200-day cushion (+4.8%) and negative trailing year (-34.3%) mark a genuine trend test |
| 📈 ACCUMULATE | BB | Recovered out of oversold; watch for confirmation the bounce holds |
What To Watch Next
| Watch | Why it matters |
|---|---|
| OKTA's follow-through | Confirm whether the earnings-beat rally and target-raise wave hold or fade |
| ZS's 200-day level | Still the one name genuinely testing its long trend despite this week's gain |
| Whether CRWD's full reversal holds | Erased last scan's steepest weekly drop in a single week |
| BB's continued recovery | Just cleared oversold; confirm the bounce extends |
Sources
- Tape data (price/RSI/SMA/returns/long-horizon): full-scan pre-computed summaries as of the 2026-08-28 close — cybersec.
- OKTA news receipt checked (latest, fetched 2026-08-27, fresh): Q2 2027 earnings reported Aug 26; price-target raises from Truist, Scotiabank, RBC Capital, and Needham all dated Aug 27.
Related
10 eventsNo direct external sources are attached to this read.